TRAT.REUMATISMO POR EL PIRAMIDON- PIRAZOLIDINA
Leído
3784
Vecesse ha leído el artículo
3687
Total PDF
97
Total HTML
Información del artículo
ISSN: 00142565Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 5 | 0 | 3 | 3 |
| 2025 4 | 0 | 1 | 1 |
| 2025 3 | 0 | 8 | 8 |
| 2025 2 | 0 | 10 | 10 |
| 2025 1 | 0 | 4 | 4 |
| 2024 12 | 0 | 3 | 3 |
| 2024 11 | 0 | 3 | 3 |
| 2024 10 | 0 | 10 | 10 |
| 2024 9 | 0 | 19 | 19 |
| 2024 8 | 0 | 13 | 13 |
| 2024 7 | 0 | 8 | 8 |
| 2024 6 | 0 | 8 | 8 |
| 2024 5 | 0 | 26 | 26 |
| 2024 4 | 0 | 21 | 21 |
| 2024 3 | 0 | 48 | 48 |
| 2024 2 | 0 | 10 | 10 |
| 2024 1 | 0 | 11 | 11 |
| 2023 12 | 0 | 29 | 29 |
| 2023 11 | 0 | 76 | 76 |
| 2023 10 | 0 | 94 | 94 |
| 2023 9 | 0 | 51 | 51 |
| 2023 8 | 0 | 60 | 60 |
| 2023 7 | 0 | 72 | 72 |
| 2023 6 | 0 | 86 | 86 |
| 2023 5 | 0 | 61 | 61 |
| 2023 4 | 0 | 106 | 106 |
| 2023 3 | 4 | 110 | 114 |
| 2023 2 | 0 | 86 | 86 |
| 2022 1 | 0 | 77 | 77 |
| 2022 12 | 0 | 82 | 82 |
| 2022 11 | 0 | 84 | 84 |
| 2022 10 | 0 | 82 | 82 |
| 2022 9 | 0 | 104 | 104 |
| 2022 8 | 0 | 64 | 64 |
| 2022 7 | 0 | 54 | 54 |
| 2022 6 | 0 | 66 | 66 |
| 2022 5 | 0 | 60 | 60 |
| 2022 4 | 0 | 64 | 64 |
| 2022 3 | 0 | 78 | 78 |
| 2022 2 | 0 | 60 | 60 |
| 2021 1 | 0 | 99 | 99 |
| 2021 12 | 0 | 92 | 92 |
| 2021 11 | 0 | 83 | 83 |
| 2021 10 | 0 | 81 | 81 |
| 2021 9 | 0 | 81 | 81 |
| 2021 8 | 0 | 60 | 60 |
| 2021 7 | 0 | 68 | 68 |
| 2021 6 | 0 | 48 | 48 |
| 2021 5 | 0 | 46 | 46 |
| 2021 4 | 0 | 158 | 158 |
| 2021 3 | 0 | 83 | 83 |
| 2021 2 | 0 | 37 | 37 |
| 2020 1 | 0 | 34 | 34 |
| 2020 12 | 0 | 6 | 6 |
| 2020 11 | 0 | 3 | 3 |
| 2020 10 | 0 | 55 | 55 |
| 2020 9 | 0 | 42 | 42 |
| 2020 8 | 0 | 44 | 44 |
| 2020 7 | 0 | 29 | 29 |
| 2020 6 | 0 | 37 | 37 |
| 2020 5 | 0 | 28 | 28 |
| 2020 4 | 0 | 32 | 32 |
| 2020 3 | 0 | 26 | 26 |
| 2020 2 | 0 | 23 | 23 |
| 2020 1 | 0 | 25 | 25 |
| 2019 12 | 0 | 14 | 14 |
| 2019 11 | 0 | 12 | 12 |
| 2019 10 | 0 | 17 | 17 |
| 2019 9 | 0 | 23 | 23 |
| 2019 8 | 0 | 16 | 16 |
| 2019 7 | 0 | 19 | 19 |
| 2019 6 | 0 | 35 | 35 |
| 2019 5 | 0 | 65 | 65 |
| 2019 4 | 0 | 54 | 54 |
| 2019 3 | 0 | 8 | 8 |
| 2019 2 | 0 | 11 | 11 |
| 2019 1 | 0 | 9 | 9 |
| 2018 12 | 0 | 11 | 11 |
| 2018 11 | 0 | 6 | 6 |
| 2018 2 | 1 | 3 | 4 |
| 2018 1 | 4 | 3 | 7 |
| 2017 12 | 2 | 5 | 7 |
| 2017 11 | 2 | 7 | 9 |
| 2017 10 | 3 | 12 | 15 |
| 2017 9 | 2 | 5 | 7 |
| 2017 8 | 1 | 5 | 6 |
| 2017 7 | 6 | 12 | 18 |
| 2017 6 | 3 | 6 | 9 |
| 2017 5 | 2 | 7 | 9 |
| 2017 4 | 5 | 9 | 14 |
| 2017 3 | 8 | 16 | 24 |
| 2017 2 | 1 | 8 | 9 |
| 2016 1 | 4 | 5 | 9 |
| 2016 12 | 6 | 7 | 13 |
| 2016 11 | 4 | 13 | 17 |
| 2016 10 | 7 | 11 | 18 |
| 2016 9 | 13 | 12 | 25 |
| 2016 8 | 9 | 6 | 15 |
| 2016 7 | 8 | 3 | 11 |
| 2015 12 | 1 | 0 | 1 |
| 2015 8 | 1 | 0 | 1 |
Mostrar todo
